Pregled bibliografske jedinice broj: 686500
Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1, 4- dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1, 4- dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor. // Journal of neurochemistry, 126 (2013), 5; 616-624 doi:10.1111/jnc.12354 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 686500 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1, 4- dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
Autori
Mu, Linjing ; Bieri, Daniel ; Slavik, Roger ; Drandarov, Konstantin ; Müller, Adrienne ; Čermak, Stjepko ; Weber, Markus ; Krämer, Stefanie D. ; Schibli, Roger ; Ametamey, Simon M. ;
Izvornik
Journal of neurochemistry (0022-3042) 126
(2013), 5;
616-624
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
autoradiography; cannabinoid receptor type 2 ligand; neurodegeneration; radiolabeling; small-animal PET
Sažetak
The cannabinoid type 2 (CB2) receptor plays an important role in neuroinflammatory and neurodegenerative diseases such as multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer’s disease and is therefore a very promising target for therapeutic approaches as well as for imaging. Based on the literature, we identified one 4-oxoquinoline derivative(designated KD2) as the lead structure. It was synthesized, radiolabeled and evaluated as a potential imaging tracer for CB2. [11C]KD2 was obtained in 99% radiochemical purity.Moderate blood–brain barrier (BBB) passage was predicted for KD2 from an in vitro transport assay with P- glycoprotein-transfected Madin Darby canine kidney cells. No efflux of KD2 by P-glycoprotein was detected. In vitro autoradiography of rat and mouse spleen slices demonstrated that [11C]KD2 exhibits high specific binding towards CB2. High spleen uptake of [11C]KD2 was observed in dynamic positron emission tomography(PET) studies with Wistar rats and its specificity was confirmed by displacement study with a selective CB2 agonist, GW405833. A pilot autoradiography study with post- mortem spinal cord slices from amyotrophic lateral sclerosis (ALS)patients with [11C]KD2 suggested the presence of CB2 receptors under disease conditions. Specificity of [11C]KD2 binding could also be demonstrated on these human tissues. In conclusion, [11C]KD2 shows good in vitro and in vivo properties as a potential PET tracer for CB2.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Temeljne medicinske znanosti, Farmacija
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE